IOL Chemicals and Pharmaceuticals Limited has issued a communication to shareholders who have not registered their email addresses, providing a web-link to access the Notice for its 39th Annual General Meeting (AGM) and the Integrated Annual Report for FY26. This disclosure, made pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensures that all members can access critical corporate governance documents despite the company’s shift to electronic-only distribution for registered users. The AGM is scheduled for September 2, 2026, and will address key resolutions including the adoption of financial statements which reported a standalone revenue of ₹2,319.06 crore and a profit after tax (PAT) of ₹137.72 crore for FY26.

Communication to Unregistered Shareholders

The company clarified that physical copies of the Annual Report are not being dispatched. Instead, shareholders without registered email IDs with the Company, Registrar and Transfer Agent (RTA), or Depository Participants (DPs) must access the documents digitally. The notice, dated August 7, 2026, and signed by Sr. Vice President & Company Secretary Abhay Raj Singh, directs these members to scan a QR code or visit the company’s investor relations website at https://www.iolcp.com/investors/annual-reports .

The documents are also available on the websites of BSE Limited, National Stock Exchange of India Limited, and Central Depository Services Limited (CDSL) at https://www.evotingindia.com . This move aligns with regulatory efforts to promote paperless corporate communications while maintaining transparency for all stakeholders.

AGM Details and Shareholder Action Required

The 39th AGM will be held on Wednesday, September 2, 2026, at 11:30 a.m. (IST) via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Members holding shares in physical mode or those with outdated email records are urged to update their details immediately to facilitate smooth participation and future dividend processing.

Shareholders can contact the RTA, Alankit Assignments Limited, at +91-11-4254 1234 / 4254 1958 for assistance. The Register of Members will remain closed from August 27, 2026, to September 2, 2026.

Voting and Compliance

Remote e-voting will be facilitated by CDSL, with the voting window opening on August 30, 2026, at 9:00 a.m. and closing on September 1, 2026, at 5:00 p.m. Only shareholders on the record date of August 26, 2026, are eligible to vote. The facility for appointing proxies is not available for this meeting, though institutional shareholders may appoint authorized representatives under Section 113 of the Companies Act, 2013. Mr. Vinay Kohli of M/s K.K. Kapoor & Associates has been appointed as the scrutinizer for the e-voting process.

IOL Chemicals & Pharmaceuticals reported a robust start to FY26, with standalone net profit rising 89.9% year-on-year to ₹64.48 crore for the quarter ended June 30, 2026. The chemical manufacturer’s total income from operations expanded to ₹764.44 crore, up from ₹559.06 crore in Q1FY25, reflecting strong top-line momentum and improved operational efficiency across its business segments.

The results were approved by the Board of Directors at their meeting held on August 10, 2026, following review by the Audit Committee. The unaudited financial results were published in Business Standard, Economic Times, Financial Express, and Punjabi Jagran on August 11, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors expressed an unmodified opinion on these results after a limited review.

Financial Performance Overview

IOL Chemicals & Pharmaceuticals demonstrated significant growth in both revenue and profitability metrics during the quarter. The company’s net profit before tax stood at ₹86.77 crore, compared to ₹45.54 crore in the corresponding period of the previous year. This improvement was underpinned by a substantial increase in total income from operations, which grew by approximately 36.7% year-on-year.

On a consolidated basis, the net profit after tax was ₹64.40 crore, compared to ₹33.93 crore in Q1FY25. Consolidated total income from operations remained consistent with standalone figures at ₹764.44 crore for the quarter.

Profitability and Operational Efficiency

The near-doubling of net profit highlights improved cost management and higher margins relative to the previous year. The company’s earnings per share (basic and diluted) increased to ₹2.20 per equity share, up from ₹1.16 in the year-ago quarter. This growth in EPS underscores the enhanced value creation for shareholders driven by the stronger bottom-line performance.

Total comprehensive income for the period, comprising profit after tax and other comprehensive income, stood at ₹63.45 crore on a standalone basis, compared to ₹33.32 crore in Q1FY25. The reserves excluding revaluation reserve also saw an increase, rising to ₹1,803.12 crore as of June 30, 2026, from ₹1,662.02 crore at the end of the previous financial year.

What the Numbers Show

The data indicates a clear acceleration in profitability outpacing revenue growth. While revenue grew by roughly 36.7%, net profit surged by nearly 90%, suggesting significant operating leverage or favorable mix shifts within the product portfolio. The expansion in reserves by over ₹140 crore year-on-year further strengthens the balance sheet, providing a solid foundation for future capital allocation or debt reduction strategies.